|
1
|
Olnes MJ and Erlich R: A review and update
on cholangiocarcinoma. Oncology. 66:167–179. 2004.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yao KJ, Jabbour S, Parekh N, Lin Y and
Moss RA: Increasing mortality in the United States from
cholangiocarcinoma: An analysis of the National Center for Health
Statistics Database. BMC Gastroenterol. 16(117)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Landis SH, Murray T, Bolden S and Wingo
PA: Cancer statistics, 1998. CA Cancer J Clin. 48:6–29.
1998.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hasegawa S, Ikai I, Fujii H, Hatano E and
Shimahara Y: Surgical resection of hilar cholangiocarcinoma:
Analysis of survival and postoperative complications. World J Surg.
31:1256–1263. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Khan SA, Davidson BR, Goldin RD, Heaton N,
Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD,
Thillainayagam AV, et al: British Society of Gastroenterology:
Guidelines for the diagnosis and treatment of cholangiocarcinoma:
An update. Gut. 61:1657–1669. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hopfner M, Schuppan D and Scherubl H:
Targeted medical therapy of biliary tract cancer: Recent advances
and future perspectives. World J Gastroenterol. 14:7021–7032.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Leelawat K, Leelawat S, Tepaksorn P,
Rattanasinganchan P, Leungchaweng A, Tohtong R and Sobhon P:
Involvement of c-Met/hepatocyte growth factor pathway in
cholangiocarcinoma cell invasion and its therapeutic inhibition
with small interfering RNA specific for c-Met. J Surg Res.
136:78–84. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Leelawat K, Leelawat S, Narong S and
Hongeng S: Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4
induced cholangiocarcinoma cell invasion. World J Gastroenterol.
13:1561–1568. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li Q and Yang Z: Expression of
phospho-ERK1/2 and PI3-K in benign and malignant gallbladder
lesions and its clinical and pathological correlations. J Exp Clin
Cancer Res. 28(65)2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kaiser RA, Liang Q, Bueno O, Huang Y,
Lackey T, Klevitsky R, Hewett TE and Molkentin JD: Genetic
inhibition or activation of JNK1/2 protects the myocardium from
ischemia-reperfusion-induced cell death in vivo. J Biol Chem.
280:32602–32608. 2005.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang XT, Pei DS, Xu J, Guan QH, Sun YF,
Liu XM and Zhang GY: Opposing effects of Bad phosphorylation at two
distinct sites by Akt1 and JNK1/2 on ischemic brain injury. Cell
Signal. 19:1844–1856. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cuenda A and Rousseau S: p38 MAP-kinases
pathway regulation, function and role in human diseases. Biochim
Biophys Acta. 1773:1358–1375. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yamagiwa Y, Marienfeld C, Tadlock L and
Patel T: Translational regulation by p38 mitogen-activated protein
kinase signaling during human cholangiocarcinoma growth.
Hepatology. 38:158–166. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Saralamp P, Chuakul W, Temsiririrkkul R
and Clayton T: Medicinal plants in Thailand. Vol. 1. Amarin
Printing and Publishing Public Co., Ltd Bangkok, pp209-211,
1996.
|
|
16
|
Asano J, Chiba K, Tada M and Yoshii T:
Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry.
41:815–820. 1996.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sukpondma Y, Rukachaisirikul V and
Phongpaichit S: Antibacterial caged-tetraprenylated xanthones from
the fruits of Garcinia hanburyi. Chem Pharm Bull (Tokyo).
53:850–852. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Han QB, Wang YL, Yang L, Tso TF, Qiao CF,
Song JZ, Xu LJ, Chen SL, Yang DJ and Xu HX: Cytotoxic
polyprenylated xanthones from the resin of Garcinia
hanburyi. Chem Pharm Bull (Tokyo). 54:265–267. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hahnvajanawong C, Boonyanugomol W,
Nasomyon T, Loilome W, Namwat N, Anantachoke N, Tassaneeyakul W,
Sripa B, Namwat W and Reutrakul V: Apoptotic activity of caged
xanthones from Garcinia hanburyi in cholangiocarcinoma cell
lines. World J Gastroenterol. 16:2235–2243. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Boueroy P, Hahnvajanawong C, Boonmars T,
Saensa-ard S, Wattanawongdon W, Kongsanthia C, Salao K, Wongwajana
S, Anantachoke N and Reutrakul V: Synergistic effect of forbesione
from Garcinia hanburyi in combination with 5-fluorouracil on
cholangiocarcinoma. Asian Pac J Cancer Prev. 18:3343–3351.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Qi Q, Lu N, Wang XT, Gu HY, Yang Y, Liu W,
Li C, You QD and Guo QL: Anti-invasive effect of gambogic acid in
MDA-MB-231 human breast carcinoma cells. Biochem Cell Biol.
86:386–395. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Gupta SC, Kim JH, Prasad S and Aggarwal
BB: Regulation of survival, proliferation, invasion, angiogenesis,
and metastasis of tumor cells through modulation of inflammatory
pathways by nutraceuticals. Cancer Metastasis Rev. 29:405–434.
2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Reutrakul V, Anantachoke N, Pohmakotr M,
Jaipetch T, Sophasan S, Yoosook C, Kasisit J, Napaswat C, Santisuk
T and Tuchinda P: Cytotoxic and anti HIV 1 caged xanthones from the
resin and fruits of garcinia hanburyi. Planta Med. 73:33–40.
2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pinmai K, Chunlaratthanabhorn S,
Ngamkitidechakul C, Soonthornchareon N and Hahnvajanawong C:
Synergistic growth inhibitory effects of Phyllanthus emblica
and Terminalia bellerica extracts with conventional
cytotoxic agents: Doxorubicin and cisplatin against human
hepatocellular carcinoma and lung cancer cells. World J
Gastroenterol. 14:1491–1497. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lu Y, Jiang F, Jiang H, Wu K, Zheng X, Cai
Y, Katakowski M, Chopp M and To SS: Gallic acid suppresses cell
viability, proliferation, invasion and angiogenesis in human glioma
cells. Eur J Pharmacol. 641:102–107. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Albini A, Iwamoto Y, Kleinman HK, Martin
GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay
for quantitating the invasive potential of tumor cells. Cancer Res.
47:3239–3245. 1987.PubMed/NCBI
|
|
27
|
Heussen C and Dowdle EB: Electrophoretic
analysis of plasminogen activators in polyacrylamide gels
containing sodium dodecyl sulfate and copolymerized substrates.
Anal Biochem. 102:196–202. 1980.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wattanawongdon W, Hahnvajanawong C, Namwat
N, Kanchanawat S, Boonmars T, Jearanaikoon P, Leelayuwat C,
Techasen A and Seubwai W: Establishment and characterization of
gemcitabine-resistant human cholangiocarcinoma cell lines with
multidrug resistance and enhanced invasiveness. Int J Oncol.
47:398–410. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Librach CL, Werb Z, Fitzgerald ML, Chiu K,
Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH and Fisher
SJ: 92-kD type IV collagenase mediates invasion of human
cytotrophoblasts. J Cell Biol. 113:437–449. 1991.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Essafi Rhouma H, Trabelsi N, Chimento A,
Benincasa C, Tamaalli A, Perri E, Zarrouk M and Pezzi V: Olea
europaea L. Flowers as a new promising anticancer natural
product: Phenolic composition, antiproliferative activity and
apoptosis induction. Nat Prod Res. 5:1–4. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
El-Garawani IM, Elkhateeb WA, Zaghlol GM,
Almeer RS, Ahmed EF, Rateb ME and Abdel Moneim AE: Candelariella
vitellina extract triggers in vitro and in vivo cell death
through induction of apoptosis: A novel anticancer agent. Food Chem
Toxicol. 127:110–119. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Craig WJ: Health-promoting properties of
common herbs. Am J Clin Nutr. 70 (Suppl):491S–499S. 1999.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cao Y, Fu ZD, Wang F, Liu HY and Han R:
Anti-angiogenic activity of resveratrol, a natural compound from
medicinal plants. J Asian Nat Prod Res. 7:205–213. 2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lee YC, Cheng TH, Lee JS, Chen JH, Liao
YC, Fong Y, Wu CH and Shih YW: Nobiletin, a citrus flavonoid,
suppresses invasion and migration involving FAK/PI3K/Akt and small
GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell
Biochem. 347:103–115. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kunnumakkara AB, Anand P and Aggarwal BB:
Curcumin inhibits proliferation, invasion, angiogenesis and
metastasis of different cancers through interaction with multiple
cell signaling proteins. Cancer Lett. 269:199–225. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Boueroy P, Saensa-Ard S, Siripong P,
Kanthawong S and Hahnvajanawong C: Rhinacanthin-C extracted from
Rhinacanthus nasutus (L.) inhibits cholangiocarcinoma cell
migration and invasion by decreasing MMP-2, uPA, FAK and MAPK
pathways. Asian Pac J Cancer Prev. 19:3605–3613. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jonkman JE, Cathcart JA, Xu F, Bartolini
ME, Amon JE, Stevens KM and Colarusso P: An introduction to the
wound healing assay using live-cell microscopy. Cell Adhes Migr.
8:440–451. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Stamm A, Strauß S, Vogt P, Scheper T and
Pepelanova I: Positive in vitro wound healing effects of functional
inclusion bodies of a lipoxygenase from the Mexican axolotl. Microb
Cell Fact. 17(57)2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Latifi-Pupovci H, Kuçi Z, Wehner S, Bönig
H, Lieberz R, Klingebiel T, Bader P and Kuçi S: In vitro migration
and proliferation (“wound healing”) potential of mesenchymal
stromal cells generated from human CD271+ bone marrow
mononuclear cells. J Transl Med. 13(315)2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mon NN, Hasegawa H, Thant AA, Huang P,
Tanimura Y, Senga T and Hamaguchi M: A role for focal adhesion
kinase signaling in tumor necrosis factor-α-dependent matrix
metalloproteinase-9 production in a cholangiocarcinoma cell line,
CCKS1. Cancer Res. 66:6778–6784. 2006.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Weiner TM, Liu ET, Craven RJ and Cance WG:
Expression of focal adhesion kinase gene and invasive cancer.
Lancet. 342:1024–1025. 1993.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Seko Y, Takahashi N, Tobe K, Kadowaki T
and Yazaki Y and Yazaki Y: Pulsatile stretch activates
mitogen-activated protein kinase (MAPK) family members and focal
adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes.
Biochem Biophys Res Commun. 259:8–14. 1999.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Blobe GC, Obeid LM and Hannun YA:
Regulation of protein kinase C and role in cancer biology. Cancer
Metastasis Rev. 13:411–431. 1994.PubMed/NCBI View Article : Google Scholar
|
|
45
|
O'Brian C, Vogel VG, Singletary SE and
Ward NE: Elevated protein kinase C expression in human breast tumor
biopsies relative to normal breast tissue. Cancer Res.
49:3215–3217. 1989.PubMed/NCBI
|
|
46
|
Shen KH, Hung SH, Yin LT, Huang CS, Chao
CH, Liu CL and Shih YW: Acacetin, a flavonoid, inhibits the
invasion and migration of human prostate cancer DU145 cells via
inactivation of the p38 MAPK signaling pathway. Mol Cell Biochem.
333:279–291. 2010.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Oya M, Takayanagi A, Horiguchi A, Mizuno
R, Ohtsubo M, Marumo K, Shimizu N and Murai M: Increased nuclear
factor-kappa B activation is related to the tumor development of
renal cell carcinoma. Carcinogenesis. 24:377–384. 2003.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Katiyar SK and Meeran SM: Obesity
increases the risk of UV radiation-induced oxidative stress and
activation of MAPK and NF-kappaB signaling. Free Radic Biol Med.
42:299–310. 2007.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-κB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Neil JR, Johnson KM, Nemenoff RA and
Schiemann WP: Cox-2 inactivates Smad signaling and enhances EMT
stimulated by TGF-beta through a PGE2-dependent mechanisms.
Carcinogenesis. 29:2227–2235. 2008.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Endo K, Yoon BI, Pairojkul C, Demetris AJ
and Sirica AE: ERBB-2 overexpression and cyclooxygenase-2
up-regulation in human cholangiocarcinoma and risk conditions.
Hepatology. 36:439–450. 2002.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Stasinopoulos I, Shah T, Penet MF,
Krishnamachary B and Bhujwalla ZM: COX-2 in cancer: Gordian knot or
Achilles heel? Front Pharmacol. 4(34)2013.PubMed/NCBI View Article : Google Scholar
|
